A scanner developed in Aberdeen may be probably “extraordinary” for diagnosis and treatment of breast cancer, claiming.

Scientists at the University of Aberdeen used a prototype version of the new field cycling image (FCI) scanner to check the breast tissue of new-diagnosed patients with cancer.

He said that he found that FCI scanner can distinguish tumor content from healthy tissue with more accuracy than current magnetic resonance imaging (MRI) methods.

Whereas MRI similar – which was Also developed in eberdine – FCI scanner is described as being able to separate the strength of the magnetic field during the patient’s scan.

The university described the scanner as “World First”, which could identify “pre -undesirable cancer tumor invasion”.

Scientists worked on the study in collaboration with NHS Grammpion.

The technique capable of detecting tumors without injecting dye in the body was described as another benefit.

The team stated that success with breast tissue first followed positive results when prototypes were used to identify brain damage due to a stroke.

Dr. Lionel broke is a senior research partner in biomedical physics and lead researcher in the study.

“We found that the pictures produced from FCI could portray the breast tumor more accurately,” he said.

“This means that it can improve the treatment plan for patients by improving the accuracy of biopsy procedures by better detection of the type and location of the tumor, and by reducing the surgery repeatedly, in fact, on patients The potential effect is extraordinary. “

He said: “My colleagues at the University of Aberdeen built the world’s first clinical MRI in the 1970s, so it is both fitting and exciting that we have made waves again with a completely new type of MRI called FCI. Are you

“This is actually an exciting innovation and as we keep improving technology for FCI, the ability to clinical applications is infinite.”

Dr. Gerald Lip is an advisor to the NHS Grampion Radiologist and co-conducts in the study, recently appointed as the chairman of the British Society of Breast Radiology.

“This data is very promising, and we still need more possible work, but these results will actually support future clinical applications,” he said.

“We treat 400 and 500 women with breast cancer in NHS Grampian every year and this technique is likely to reduce the need to return women for additional surgery, benefiting them and waiting time and operation theater resources To reduce

“We hope that the future will play a role in supporting cancer diagnosis and management.”